"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 15 | 15 |
| 1995 | 0 | 14 | 14 |
| 1996 | 0 | 15 | 15 |
| 1997 | 0 | 22 | 22 |
| 1998 | 0 | 21 | 21 |
| 1999 | 0 | 11 | 11 |
| 2000 | 0 | 24 | 24 |
| 2001 | 0 | 30 | 30 |
| 2002 | 0 | 31 | 31 |
| 2003 | 0 | 32 | 32 |
| 2004 | 0 | 41 | 41 |
| 2005 | 0 | 37 | 37 |
| 2006 | 0 | 33 | 33 |
| 2007 | 0 | 52 | 52 |
| 2008 | 0 | 57 | 57 |
| 2009 | 0 | 67 | 67 |
| 2010 | 0 | 64 | 64 |
| 2011 | 0 | 72 | 72 |
| 2012 | 0 | 80 | 80 |
| 2013 | 0 | 76 | 76 |
| 2014 | 0 | 70 | 70 |
| 2015 | 0 | 61 | 61 |
| 2016 | 0 | 93 | 93 |
| 2017 | 0 | 100 | 100 |
| 2018 | 0 | 79 | 79 |
| 2019 | 0 | 91 | 91 |
| 2020 | 0 | 79 | 79 |
| 2021 | 0 | 59 | 59 |
| 2022 | 0 | 13 | 13 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 14 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Canaloplasty via an ab-interno surgical technique in patients with primary angle closure glaucoma. Int Ophthalmol. 2024 Oct 04; 44(1):401.
-
Validation of Prognostic Scales for Functional Outcome in Ischemic Stroke Patients Treated with Intravenous Thrombolysis in a Rural Setting. Cerebrovasc Dis Extra. 2024; 14(1):148-157.
-
PF-06952229, a selective TGF-?-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors. ESMO Open. 2024 Sep; 9(9):103653.
-
Laparoscopic Cholecystectomy in Cardiogenic Shock And Heart Failure. J Laparoendosc Adv Surg Tech A. 2024 Sep; 34(9):829-835.
-
Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2. Oncologist. 2024 Aug 05; 29(8):690-698.
-
Capturing the perspectives of African American informal dementia caregivers: a phenomenological study. Ethn Health. 2024 Aug; 29(6):579-596.
-
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial. Ann Oncol. 2024 Aug; 35(8):728-738.
-
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study. Gynecol Oncol. 2024 06; 185:202-211.
-
Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70?years and over. Gynecol Oncol. 2024 08; 187:221-226.
-
Refractive Astigmatism Outcomes of Femtosecond Laser-Assisted Arcuate Keratotomies Combined with Femtosecond Laser-Assisted Cataract Surgery: Two-Year Results. Curr Eye Res. 2024 Sep; 49(9):961-971.